Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Publications

Search Items: MULTIPLE SCLEROSIS, . hits: 426

2023

Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Maceski, AM; Benkert, P; Bachmaier, G; Ropele, S; Reindl, M; Leppert, D; Kuhle, J; Enzinger, C; Khalil, M High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis.
Eur J Neurol. 2023; 30(5):1389-1399 Doi: 10.1111/ene.15742
Web of Science PubMed FullText FullText_MUG

Callegari, I; Schneider, M; Aebischer, V; Voortman, MM; Proschmann, U; Ziemssen, T; Lindberg, R; Fischer-Barnicol, B; Khalil, M; Kappos, L; Kuhle, J; Sanderson, NSR; Derfuss, T Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis.
Ther Adv Neurol Disord. 2023; 16: 17562864221150040 Doi: 10.1177/17562864221150040 [OPEN ACCESS]
PubMed FullText FullText_MUG

Guger, M; Enzinger, C; Leutmezer, F; Di, Pauli, F; Kraus, J; Kalcher, S; Kvas, E; Berger, T, , Austrian, MS, Treatment, Registry, (AMSTR) Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing-remitting multiple sclerosis in Austria.
J Neurol. 2023; Doi: 10.1007/s00415-023-11644-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Hegen, H; Arrambide, G; Gnanapavan, S; Kaplan, B; Khalil, M; Saadeh, R; Teunissen, C; Tumani, H; Villar, LM; Willrich, MAV; Zetterberg, H; Deisenhammer, F Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
Mult Scler. 2023; 29(2):182-195 Doi: 10.1177/13524585221134217 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Hegen, H; Berek, K; Bsteh, G; Auer, M; Altmann, P; Di Pauli, F; Grams, A; Milosavljevic, D; Ponleitner, M; Poskaite, P; Schnabl, C; Wurth, S; Zinganell, A; Berger, T; Walde, J; Deisenhammer, F Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study
EBIOMEDICINE. 2023; 91: 1-9. Doi: 10.1016/j.ebiom.2023.104573 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Hegen, H; Walde, J; Berek, K; Arrambide, G; Gnanapavan, S; Kaplan, B; Khalil, M; Saadeh, R; Teunissen, C; Tumani, H; Villar, LM; Willrich, MAV; Zetterberg, H; Deisenhammer, F Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
Mult Scler. 2022; 13524585221134213 Doi: 10.1177/13524585221134213 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Meier, S; Willemse, EAJ; Schaedelin, S; Oechtering, J; Lorscheider, J; Melie-Garcia, L; Cagol, A; Barakovic, M; Galbusera, R; Subramaniam, S; Barro, C; Abdelhak, A; Thebault, S; Achtnichts, L; Lalive, P; Müller, S; Pot, C; Salmen, A; Disanto, G; Zecca, C; D'Souza, M; Orleth, A; Khalil, M; Buchmann, A; Du, Pasquier, R; Yaldizli, Ö; Derfuss, T; Berger, K; Hermesdorf, M; Wiendl, H; Piehl, F; Battaglini, M; Fischer, U; Kappos, L; Gobbi, C; Granziera, C; Bridel, C; Leppert, D; Maleska, Maceski, A; Benkert, P; Kuhle, J Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
JAMA Neurol. 2023; 80(3):287-97 Doi: 10.1001/jamaneurol.2022.5250 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Monschein, T; Dekany, S; Zrzavy, T; Ponleitner, M; Altmann, P; Bsteh, G; Kornek, B; Rommer, P; Enzinger, C; Di, Pauli, F; Kraus, J; Berger, T; Leutmezer, F; Guger, M, , Austrian, MS, Treatment, Registry, (AMSTR) Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR).
J Neurol. 2023; Doi: 10.1007/s00415-023-11686-2
Web of Science PubMed FullText FullText_MUG

Seiberl, M; Feige, J; Hilpold, P; Hitzl, W; Machegger, L; Buchmann, A; Khalil, M; Trinka, E; Harrer, A; Wipfler, P; Moser, T Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting.
Int J Mol Sci. 2023; 24(4): Doi: 10.3390/ijms24044067 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2022

Benkert, P; Meier, S; Schaedelin, S; Manouchehrinia, A; Yaldizli, Ö; Maceski, A; Oechtering, J; Achtnichts, L; Conen, D; Derfuss, T; Lalive, PH; Mueller, C; Müller, S; Naegelin, Y; Oksenberg, JR; Pot, C; Salmen, A; Willemse, E; Kockum, I; Blennow, K; Zetterberg, H; Gobbi, C; Kappos, L; Wiendl, H; Berger, K; Sormani, MP; Granziera, C; Piehl, F; Leppert, D; Kuhle, J, , NfL, Reference, Database, in, the, Swiss, Multiple, Sclerosis, Cohort, Study, Group Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
Lancet Neurol. 2022; 21(3): 246-257. Doi: 10.1016/S1474-4422(22)00009-6
Web of Science PubMed FullText FullText_MUG

Bsteh, G; Assar, H; Gradl, C; Heschl, B; Hiller, MS; Krajnc, N; Di, Pauli, F; Hegen, H; Traxler, G; Leutmezer, F; Wipfler, P; Zulehner, G; Guger, M; Enzinger, C; Berger, T, , AUT-MuSC-19, investigators Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multicenter matched-control study.
Eur J Neurol. 2022; Doi: 10.1111/ene.15477 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Bsteh, G; Gradl, C; Heschl, B; Hegen, H; Di, Pauli, F; Assar, H; Leutmezer, F; Traxler, G; Krajnc, N; Zulehner, G; Hiller, MS; Rommer, P; Wipfler, P; Guger, M; Enzinger, C; Berger, T, , AUT-MuSC, investigators Impact of vaccination on COVID-19 outcome in multiple sclerosis.
Eur J Neurol. 2022; Doi: 10.1111/ene.15488 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Bsteh, G; Hegen, H; Berek, K; Altmann, P; Auer, M; Di Pauli, F; Haider, L; Leutmezer, F; Rommer, P; Walchhofer, LM; Wurth, S; Zinganell, A; Deisenhammer, F; Berger, T Olfactory threshold predicts treatment response in relapsing multiple sclerosis
MULT SCLER J. 2022; 13524585221079744 Doi: 10.1177/13524585221079744
Web of Science PubMed FullText FullText_MUG

Dahaba, AA; Bornemann-Cimenti, H Migraine, interferon β1a and siponimod immunomodulator therapies.
BMC Anesthesiol. 2022; 22(1): 95 Doi: 10.1186/s12871-022-01639-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Filippi, M; Preziosa, P; Meani, A; Dalla, Costa, G; Mesaros, S; Drulovic, J; Ivanovic, J; Rovira, A; Tintorè, M; Montalban, X; Ciccarelli, O; Brownlee, W; Miszkiel, K; Enzinger, C; Khalil, M; Barkhof, F; Strijbis, EMM; Frederiksen, JL; Cramer, SP; Fainardi, E; Amato, MP; Gasperini, C; Ruggieri, S; Martinelli, V; Comi, G; Rocca, MA, , MAGNIMS, Study, Group Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study.
Neurology. 2022; 98(1):e1-e14 Doi: 10.1212/WNL.0000000000013016
Web of Science PubMed FullText FullText_MUG

Hechenberger, S; Helmlinger, B; Ropele, S; Pirpamer, L; Bachmaier, G; Damulina, A; Pichler, A; Khalil, M; Enzinger, C; Pinter, D Information processing speed as a prognostic marker of physical impairment and progression in patients with multiple sclerosis.
Mult Scler Relat Disord. 2022; 57: 103353 Doi: 10.1016/j.msard.2021.103353
Web of Science PubMed FullText FullText_MUG

Jarius, S; Pache, F; Körtvelyessy, P; Jelčić, I; Stettner, M; Franciotta, D; Keller, E; Neumann, B; Ringelstein, M; Senel, M; Regeniter, A; Kalantzis, R; Willms, JF; Berthele, A; Busch, M; Capobianco, M; Eisele, A; Reichen, I; Dersch, R; Rauer, S; Sandner, K; Ayzenberg, I; Gross, CC; Hegen, H; Khalil, M; Kleiter, I; Lenhard, T; Haas, J; Aktas, O; Angstwurm, K; Kleinschnitz, C; Lewerenz, J; Tumani, H; Paul, F; Stangel, M; Ruprecht, K; Wildemann, B, , ; in, cooperation, with, the, German, Society, for, Cerebrospinal, Fluid, Diagnostics, and, Clinical, Neurochemistry Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
J Neuroinflammation. 2022; 19(1): 19 Doi: 10.1186/s12974-021-02339-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Liu, S; Han, J; Puyal, EL; Kontaxis, S; Sun, S; Locatelli, P; Dineley, J; Pokorny, FB; Costa, GD; Leocani, L; Guerrero, AI; Nos, C; Zabalza, A; Sørensen, PS; Buron, M; Magyari, M; Ranjan, Y; Rashid, Z; Conde, P; Stewart, C; Folarin, AA; Dobson, RJ; Bailón, R; Vairavan, S; Cummins, N; Narayan, VA; Hotopf, M; Comi, G; Schuller, B; Consortium, RC Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder.
Pattern Recognit. 2022; 123:108403 Doi: 10.1016/j.patcog.2021.108403 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Magyar, M; Gattringer, T; Enzinger, C; Hassler, E; Partl, R; Khalil, M; Reishofer, G; Deutschmann, H; Fazekas, F Incidence of Developmental Venous Anomalies in Patients With Multiple Sclerosis: A 3 Tesla MRI Study.
Front Neurol. 2022; 13: 824347 Doi: 10.3389/fneur.2022.824347 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Meaton, I; Altokhis, A; Allen, CM; Clarke, MA; Sinnecker, T; Meier, D; Enzinger, C; Calabrese, M; De, Stefano, N; Pitiot, A; Giorgio, A; Schoonheim, MM; Paul, F; Pawlak, MA; Schmidt, R; Granziera, C; Kappos, L; Montalban, X; Rovira, À; Wuerfel, J; Evangelou, N Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.
Mult Scler. 2022; 28(14):2212-2220 Doi: 10.1177/13524585221118677 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Oechtering, J; Lincke, T; Schaedelin, S; Décard, BF; Maceski, A; Orleth, A; Meier, S; Willemse, E; Buchmann, A; Khalil, M; Derfuss, T; Benkert, P; Heijnen, I; Regeniter, A; Müller, S; Achtnichts, L; Lalive, P; Salmen, A; Pot, C; Gobbi, C; Kappos, L; Granziera, C; Leppert, D; Schlaeger, R; Lieb, JM; Kuhle, J, , Swiss, MS, Cohort, Study Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS.
Ann Neurol. 2022; 91(6):814-820 Doi: 10.1002/ana.26348 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Paar, M; Seifried, K; Cvirn, G; Buchmann, A; Khalil, M; Oettl, K Redox State of Human Serum Albumin in Multiple Sclerosis: A Pilot Study.
Int J Mol Sci. 2022; 23(24): Doi: 10.3390/ijms232415806 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Pareto, D; Garcia-Vidal, A; Groppa, S; Gonzalez-Escamilla, G; Rocca, M; Filippi, M; Enzinger, C; Khalil, M; Llufriu, S; Tintoré, M; Sastre-Garriga, J; Rovira, À Prognosis of a second clinical event from baseline MRI in patients with a CIS: a multicenter study using a machine learning approach.
Neuroradiology. 2022; 64(7):1383-1390 Doi: 10.1007/s00234-021-02885-7
Web of Science PubMed FullText FullText_MUG

Pirpamer, L; Kincses, B; Kincses, ZT; Kiss, C; Damulina, A; Khalil, M; Stollberger, R; Schmidt, R; Enzinger, C; Ropele, S Periventricular magnetisation transfer abnormalities in early multiple sclerosis.
Neuroimage Clin. 2022; 34: 103012 Doi: 10.1016/j.nicl.2022.103012 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Schoonheim, MM; Pinter, D; Prouskas, SE; Broeders, TA; Pirpamer, L; Khalil, M; Ropele, S; Uitdehaag, BM; Barkhof, F; Enzinger, C; Geurts, JJ Disability in multiple sclerosis is related to thalamic connectivity and cortical network atrophy.
Mult Scler. 2022; 28(1):61-70 Doi: 10.1177/13524585211008743
Web of Science PubMed FullText FullText_MUG

Seebacher, B; Helmlinger, B; Pinter, D; Ehling, R; Hegen, H; Ropele, S; Reishofer, G; Enzinger, C; Brenneis, C; Deisenhammer, F Effects of actual and imagined music-cued gait training on motor functioning and brain activity in people with multiple sclerosis: protocol of a randomised parallel multicentre trial.
BMJ Open. 2022; 12(2):e056666 Doi: 10.1136/bmjopen-2021-056666 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Sibgatulin, R; Güllmar, D; Deistung, A; Enzinger, C; Ropele, S; Reichenbach, JR Magnetic susceptibility anisotropy in normal appearing white matter in multiple sclerosis from single-orientation acquisition.
Neuroimage Clin. 2022; 35:103059 Doi: 10.1016/j.nicl.2022.103059 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

van, Ballegooijen, H; van, der, Hiele, K; Enzinger, C; de, Voer, G; Visser, LH, , CONFIDENCE, Study, Group, , CONFIDENCE, Study, Group The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a.
eNeurologicalSci. 2022; 28: 100409 Doi: 10.1016/j.ensci.2022.100409 [OPEN ACCESS]
PubMed FullText FullText_MUG

Weiss, B; Pichler, A; Damulina, A; Buchmann, A; Hochmeister, S; Seifert-Held, T; Enzinger, C; Archelos, JJ; Khalil, M Evidence for an Intrathecal Immunoglobulin Synthesis by Kappa Free Light Chains in Neurological Patients with an Isolated Band in Isoelectric Focusing.
Biomedicines. 2022; 10(9): Doi: 10.3390/biomedicines10092202 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Zeitelhofer, M; Hochmeister, S; Adzemovic, MZ Editorial: Neuropathology of Autoimmune Inflammatory Demyelination Disorders
FRONT NEUROL. 2022; 13: 925216 Doi: 10.3389/fneur.2022.925216 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2021

Bsteh, G; Assar, H; Hegen, H; Heschl, B; Leutmezer, F; Di, Pauli, F; Gradl, C; Traxler, G; Zulehner, G; Rommer, P; Wipfler, P; Guger, M; Enzinger, C; Berger, T, , AUT-MuSC, investigators COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
PLoS One. 2021; 16(7): e0255316 Doi: 10.1371/journal.pone.0255316 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Bsteh, G; Berek, K; Hegen, H; Altmann, P; Wurth, S; Auer, M; Zinganell, A; Di Pauli, F; Rommer, P; Leutmezer, F; Deisenhammer, F; Berger, T Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis.
Mult Scler. 2021; 27(5):684-694 Doi: 10.1177/1352458520935724
Web of Science PubMed FullText FullText_MUG

Bsteh, G; Dürauer, S; Assar, H; Hegen, H; Heschl, B; Leutmezer, F; Pauli, FD; Gradl, C; Traxler, G; Zulehner, G; Rommer, P; Wipfler, P; Guger, M; Höftberger, R; Enzinger, C; Berger, T Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study.
Mult Scler. 2021; 13524585211049391 Doi: 10.1177/13524585211049391 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Bsteh, G; Hegen, H; Altmann, P; Auer, M; Berek, K; Di Pauli, F; Leutmezer, F; Rommer, P; Wurth, S; Zinganell, A; Zrzavy, T; Deisenhammer, F; Berger, T Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis.
Eur J Neurol. 2021; 19(4): Doi: 10.1111/ene.14829 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Bsteh, G; Hegen, H; Riedl, K; Altmann, P; Auer, M; Berek, K; Di Pauli, F; Ehling, R; Kornek, B; Monschein, T; Rinner, W; Schmied, C; Wurth, S; Zebenholzer, K; Zinganell, A; Zrzavy, T; Zulehner, G; Deisenhammer, F; Rommer, P; Leutmezer, F; Berger, T Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score.
Eur J Neurol. 2021; 28(5):1609-1616 Doi: 10.1111/ene.14705 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Burggraaff, J; Liu, Y; Prieto, JC; Simoes, J; de Sitter, A; Ruggieri, S; Brouwer, I; Lissenberg-Witte, BI; Rocca, MA; Valsasina, P; Ropele, S; Gasperini, C; Gallo, A; Pareto, D; Sastre-Garriga, J; Enzinger, C; Filippi, M; De Stefano, N; Ciccarelli, O; Hulst, HE; Wattjes, MP; Barkhof, F; Uitdehaag, BMJ; Vrenken, H; Guttmann, CRG; MAGNIMS Study Group Manual and automated tissue segmentation confirm the impact of thalamus atrophy on cognition in multiple sclerosis: A multicenter study.
Neuroimage Clin. 2021; 29:102549-102549 Doi: 10.1016/j.nicl.2020.102549 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Chard, DT; Alahmadi, AAS; Audoin, B; Charalambous, T; Enzinger, C; Hulst, HE; Rocca, MA; Rovira, À; Sastre-Garriga, J; Schoonheim, MM; Tijms, B; Tur, C; Gandini Wheeler-Kingshott, CAM; Wink, AM; Ciccarelli, O; Barkhof, F; MAGNIMS Study Group Mind the gap: from neurons to networks to outcomes in multiple sclerosis.
Nat Rev Neurol. 2021; 17(3):173-184 Doi: 10.1038/s41582-020-00439-8
Web of Science PubMed FullText FullText_MUG

de, Sitter, A; Burggraaff, J; Bartel, F; Palotai, M; Liu, Y; Simoes, J; Ruggieri, S; Schregel, K; Ropele, S; Rocca, MA; Gasperini, C; Gallo, A; Schoonheim, MM; Amann, M; Yiannakas, M; Pareto, D; Wattjes, MP; Sastre-Garriga, J; Kappos, L; Filippi, M; Enzinger, C; Frederiksen, J; Uitdehaag, B; Guttmann, CRG; Barkhof, F; Vrenken, H Development and evaluation of a manual segmentation protocol for deep grey matter in multiple sclerosis: Towards accelerated semi-automated references.
Neuroimage Clin. 2021; 30:102659 Doi: 10.1016/j.nicl.2021.102659 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Fessler, J; Angiari, S The Role of T Cell Senescence in Neurological Diseases and Its Regulation by Cellular Metabolism.
Front Immunol. 2021; 12: 706434 Doi: 10.3389/fimmu.2021.706434 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Granziera, C; Wuerfel, J; Barkhof, F; Calabrese, M; De, Stefano, N; Enzinger, C; Evangelou, N; Filippi, M; Geurts, JJG; Reich, DS; Rocca, MA; Ropele, S; Rovira, À; Sati, P; Toosy, AT; Vrenken, H; Gandini, Wheeler-Kingshott, CAM; Kappos, L, , MAGNIMS, Study, Group Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis.
Brain. 2021; 144(5): 1296-1311. Doi: 10.1093/brain/awab029 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Guger, M; Enzinger, C; Leutmezer, F; Di, Pauli, F; Kraus, J; Kalcher, S; Kvas, E; Berger, T, , Austrian, MS, Treatment, Registry, (AMSTR) Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry.
J Neurol. 2021; Doi: 10.1007/s00415-021-10559-w [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Haindl, MT; Hochmeister, S Vitamin D in Multiple Sclerosis-Lessons From Animal Studies.
FRONT NEUROL. 2021; 12: 757795 Doi: 10.3389/fneur.2021.757795 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Haindl, MT; Üçal, M; Klaus, B; Tögl, L; Dohrmann, J; Adzemovic, MZ; Enzinger, C; Hochmeister, S Anti-CD20 treatment effectively attenuates cortical pathology in a rat model of widespread cortical demyelination.
J NEUROINFLAMM. 2021; 18(1): 138 Doi: 10.1186/s12974-021-02189-w [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Moser, T; Seiberl, M; Feige, J; Bieler, L; Radlberger, RF; O'Sullivan, C; Pilz, G; Harrer, A; Schwenker, K; Haschke-Becher, E; Machegger, L; Grimm, J; Redlberger-Fritz, M; Buchmann, A; Khalil, M; Kvas, E; Trinka, E; Wipfler, P Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients.
Front Immunol. 2021; 12: 718895 Doi: 10.3389/fimmu.2021.718895 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Pham, L; Harris, T; Varosanec, M; Morgan, V; Kosa, P; Bielekova, B Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosis.
NPJ Digit Med. 2021; 4(1): 36-36. Doi: 10.1038/s41746-021-00401-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Pichler, A; Fruhwirth, V; Ropele, S; Schmidt, R; Fuchs, S; Enzinger, C Long-term course and morphological MRI correlates of cognitive function in multiple sclerosis.
Mult Scler. 2021; 27(6):954-963 Doi: 10.1177/1352458520941474
Web of Science PubMed FullText FullText_MUG

Pinter, D; Kober, SE; Fruhwirth, V; Berger, L; Damulina, A; Khalil, M; Neuper, C; Wood, G; Enzinger, C MRI correlates of cognitive improvement after home-based EEG neurofeedback training in patients with multiple sclerosis: a pilot study.
J Neurol. 2021; 268(10):3808-3816 Doi: 10.1007/s00415-021-10530-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Runtsch, MC; Ferrara, G; Angiari, S Metabolic determinants of leukocyte pathogenicity in neurological diseases.
J Neurochem. 2021; 158(1):36-58 Doi: 10.1111/jnc.15169
Web of Science PubMed FullText FullText_MUG

Üçal, M; Haindl, MT; Adzemovic, MZ; Zeitelhofer, M; Schaefer, U; Fazekas, F; Hochmeister, S Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines.
J Vis Exp. 2021; Doi: 10.3791/57879
Web of Science PubMed FullText FullText_MUG

Voortman, MM; Damulina, A; Pirpamer, L; Pinter, D; Pichler, A; Enzinger, C; Ropele, S; Bachmaier, G; Archelos, JJ; Marsche, G; Khalil, M Decreased Cerebrospinal Fluid Antioxidative Capacity Is Related to Disease Severity and Progression in Early Multiple Sclerosis.
Biomolecules. 2021; 11(9): Doi: 10.3390/biom11091264 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Show the next 50 results of search

↑ Top of page / Navigation